thiazol-5-ylmethyl ((2S,3S,5S)-5-((S)-2-(3-((2-ethylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-3-hydroxy-1,6-diphenylhexan-2-yl)carbamate;(5S,8S,10S,11S)-1-(2-Ethyl-4-thiazolyl)-10-hydroxy-2-methyl-5-(1-methylethyl)-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic Acid 5-Thiazolylmethyl Ester; Ritonavir USP Impurity F; [5S-(5R*,8R*,10R*,11R*)]-1-(2-Ethyl-4-thiazolyl)-10-hydroxy-2-methyl-5-(1-methylethyl)-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic Acid 5-Thiazolylmethyl Ester; Ritonavir EP Impurity I;2-Desisopropyl-2-ethyl Ritonavir
Ritonavir EP Impurity I is a fully characterized chemical compound used as a reference standard of API Ritonavir. The standard offered is compliant with regulatory guidelines. Ritonavir EP Impurity I is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 165315-26-4
Related products
Ritonavir EP Impurity B DiHCl (Monoacyl Valine DiHCl)
M.F.
M.W. 524.69 2 36.46
CAT# AR-R01741
CAS# 765875-58-9 (free base)
